Tsubota S - Search Results

1

Systematic characterization of seed overlap microRNA cotargeting associated with lupus pathogenesis.

Kitai H, Kato N, Ogami K, Komatsu S, Watanabe Y, Yoshino S, Koshi E, Tsubota S, Funahashi Y, Maeda T, Furuhashi K, Ishimoto T, Kosugi T, Maruyama S, Kadomatsu K, Suzuki HI. Kitai H, et al. Among authors: tsubota s. BMC Biol. 2022 Nov 11;20(1):248. doi: 10.1186/s12915-022-01447-4. BMC Biol. 2022. PMID: 36357926 Free PMC article.

2

The heparin-binding growth factor midkine: the biological activities and candidate receptors.

Kadomatsu K, Kishida S, Tsubota S. Kadomatsu K, et al. Among authors: tsubota s. J Biochem. 2013 Jun;153(6):511-21. doi: 10.1093/jb/mvt035. Epub 2013 Apr 26. J Biochem. 2013. PMID: 23625998 Review.

3

A new tumorsphere culture condition restores potentials of self-renewal and metastasis of primary neuroblastoma in a mouse neuroblastoma model.

Cao D, Kishida S, Huang P, Mu P, Tsubota S, Mizuno M, Kadomatsu K. Cao D, et al. Among authors: tsubota s. PLoS One. 2014 Jan 22;9(1):e86813. doi: 10.1371/journal.pone.0086813. eCollection 2014. PLoS One. 2014. PMID: 24466252 Free PMC article.

4

NeuroD1 promotes neuroblastoma cell growth by inducing the expression of ALK.

Lu F, Kishida S, Mu P, Huang P, Cao D, Tsubota S, Kadomatsu K. Lu F, et al. Among authors: tsubota s. Cancer Sci. 2015 Apr;106(4):390-6. doi: 10.1111/cas.12628. Epub 2015 Mar 12. Cancer Sci. 2015. PMID: 25652313 Free PMC article.

5

Neuroblastoma stem cells and CFC1.

Tsubota S, Kadomatsu K. Tsubota S, et al. Oncotarget. 2017 Jul 11;8(28):45032-45033. doi: 10.18632/oncotarget.18491. Oncotarget. 2017. PMID: 28636551 Free PMC article. No abstract available.

6

PRC2-Mediated Transcriptomic Alterations at the Embryonic Stage Govern Tumorigenesis and Clinical Outcome in MYCN-Driven Neuroblastoma.

Tsubota S, Kishida S, Shimamura T, Ohira M, Yamashita S, Cao D, Kiyonari S, Ushijima T, Kadomatsu K. Tsubota S, et al. Cancer Res. 2017 Oct 1;77(19):5259-5271. doi: 10.1158/0008-5472.CAN-16-3144. Epub 2017 Aug 14. Cancer Res. 2017. PMID: 28807939

7

Origin and mechanism of neuroblastoma.

Tsubota S, Kadomatsu K. Tsubota S, et al. Oncoscience. 2017 Sep 21;4(7-8):70-72. doi: 10.18632/oncoscience.360. eCollection 2017 Jul. Oncoscience. 2017. PMID: 28966937 Free PMC article. No abstract available.

8

Neurocan, an extracellular chondroitin sulfate proteoglycan, stimulates neuroblastoma cells to promote malignant phenotypes.

Su Z, Kishida S, Tsubota S, Sakamoto K, Cao D, Kiyonari S, Ohira M, Kamijo T, Narita A, Xu Y, Takahashi Y, Kadomatsu K. Su Z, et al. Among authors: tsubota s. Oncotarget. 2017 Nov 15;8(63):106296-106310. doi: 10.18632/oncotarget.22435. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29290949 Free PMC article.

9

Origin and initiation mechanisms of neuroblastoma.

Tsubota S, Kadomatsu K. Tsubota S, et al. Cell Tissue Res. 2018 May;372(2):211-221. doi: 10.1007/s00441-018-2796-z. Epub 2018 Feb 14. Cell Tissue Res. 2018. PMID: 29445860 Review.

10

Thymidylate synthase inhibitor raltitrexed can induce high levels of DNA damage in MYCN-amplified neuroblastoma cells.

Yamashita K, Kiyonari S, Tsubota S, Kishida S, Sakai R, Kadomatsu K. Yamashita K, et al. Among authors: tsubota s. Cancer Sci. 2020 Jul;111(7):2431-2439. doi: 10.1111/cas.14485. Epub 2020 Jun 10. Cancer Sci. 2020. PMID: 32415892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

78 results

Search Page